Cannell Capital - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 68 filers reported holding OVID THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cannell Capital ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$58,360
+38.7%
22,6200.0%0.01%
+37.5%
Q4 2022$42,073
+0.2%
22,6200.0%0.01%
-20.0%
Q3 2022$42,000
+223.1%
22,620
+280.2%
0.01%
+233.3%
Q2 2022$13,0005,9490.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
ACADIAN ASSET MANAGEMENT LLC 1,780,730$5,8390.02%
View complete list of OVID THERAPEUTICS INC shareholders